Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...

INDIANAPOLIS — House Republicans are putting forward eight bills that represent their priorities for the 2025 Indiana ...

OCALA, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM” or the "Company”) today ...

Donald Trump will be sworn in as the 47th president of the United States in on Monday. He’s promised a lot will happen on day ...

Nevada Gov. Joe Lombardo delivered his 2025 State of the State Address on Wednesday in Carson City. Here is the full text of his speech: ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

The Uttar Pradesh Public Service Commission (UPPSC) is set to conduct preliminary exams for all recruitments, including ...

Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.

Be Biopharma has secured $92m in a Series C financing round to advance its clinical programmes for haemophilia B and ...

The Drug Enforcement Administration proposed a special registration process for remote prescribing of controlled substances ...

Context Therapeutics has dosed the first subject in the Phase I trial of CTIM-76, targeting gynaecologic and testicular cancers.

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...